LOGO
LOGO

Corporate News

Salesforce.com Prices $1 Bln Of Convertible Senior Notes Due 2018

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Salesforce.com (CRM) announced the pricing of $1 billion of convertible senior notes due 2018 in a private placement to qualified institutional buyers. The company expects to settle the sale of notes to initial purchasers on March 18.

The company also granted initial purchasers of the notes an option to purchase up to an additional $150 million of notes to cover overallotments.

The interest will be payable semi-annually at a rate of 0.25% per year. The initial conversion rate is 3.7628 shares of common stock per $1,000 principal amount of notes.

In connection with the offering, salesforce.com entered into privately-negotiated convertible note hedge transactions with one or more of the initial purchasers and their affiliates and other financial institutions.

Salesforce.com also entered into privately-negotiated warrant transactions with the hedge counterparties. The strike price of the warrant transactions will initially be approximately $361.58 per share, which is 200% of the closing sale price of salesforce.com's common stock on March 12, 2013.

Salesforce.com expects to use portion of proceeds for cost of convertible note hedge transactions and the remaining proceeds for general corporate purposes.

For comments and feedback contact: editorial@rttnews.com

Business News

Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

RELATED NEWS
Latest Updates on COVID-19